The continuing problem of human African trypanosomiasis (sleeping sickness)

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Annals of Neurology

• Publication date

  2008-08-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1002/ana.21429PMID 18756506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PROTOZOAN AND HELMINTHIC INFECTIONS

  2009cited by this paper
• The fatal sleep

  2008influential reference
• Diagnosing central nervous system trypanosomiasis: two stage or not to stage?

  2008cited by this paper
• Loop-Mediated Isothermal Amplification (LAMP) Method for Rapid Detection of Trypanosoma brucei rhodesiense

  2008cited by this paper
• Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.

  2007cited by this paper
• Treatment Failure Related to Intrathecal Immunoglobulin M (IgM) Synthesis, Cerebrospinal Fluid IgM, and Interleukin-10 in Patients with Hemolymphatic-Stage Sleeping Sickness

  2007cited by this paper
• Interleukin-12p70-dependent interferon- gamma production is crucial for resistance in African trypanosomiasis.

  2007cited by this paper
• Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response.

  2007cited by this paper
• Neural-immune interactions in disorders of sleep-wakefulness organization.

  2007cited by this paper
• Animal models of human African trypanosomiasis--very useful or too far removed?

  2007cited by this paper
• Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.

  2007cited by this paper
• Nifurtimox plus Eflornithine for Late-Stage Sleeping Sickness in Uganda: A Case Series

  2007cited by this paper
• Combination therapy for sleeping sickness: a wake-up call.

  2007cited by this paper
• Clinical aspects of 2541 patients with second stage human African trypanosomiasis.

  2006cited by this paper
• Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis

  2006cited by this paper
• Diagnostic and neuropathogenesis issues in human African trypanosomiasis.

  2006influential reference
• Human African trypanosomiasis

  2006cited by this paper
• Lethal African trypanosomiasis in a traveler: MRI and neuropathology

  2006cited by this paper
• Sleep structure: a new diagnostic tool for stage determination in sleeping sickness.

  2005cited by this paper
• Sleeping sickness – human African trypanosomiasis

  2005influential reference
• The Genome of the African Trypanosome Trypanosoma brucei

  2005cited by this paper
• Options for Field Diagnosis of Human African Trypanosomiasis

  2005cited by this paper
• Review Article: Cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post‐treatment follow‐up

  2005cited by this paper
• Meningoencephalitic African trypanosomiasis: Brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology.

  2005cited by this paper
• Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier.

  2004cited by this paper
• Pathogenesis of human African trypanosomiasis

  2004cited by this paper
• Human African trypanosomiasis of the CNS: current issues and challenges.

  2004influential reference
• Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis.

  2003cited by this paper
• The trypanosomiases.

  2003cited by this paper
• Chemotherapy of human African trypanosomiasis: current and future prospects.

  2003cited by this paper
• Antigenic variation and the African trypanosome genome.

  2003cited by this paper
• The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa.

  2003cited by this paper
• Stage determination and therapeutic decision in human African trypanosomiasis: value of polymerase chain reaction and immunoglobulin M quantification on the cerebrospinal fluid of sleeping sickness patients in Côte d'Ivoire

  2003cited by this paper
• Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice.

  2003cited by this paper
• MR imaging findings in African trypansomiasis.

  2003cited by this paper
• Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen.

  2002cited by this paper
• Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa.

  2002cited by this paper
• Nitric oxide and cytokine synthesis in human African trypanosomiasis.

  2001cited by this paper
• Neurological aspects of human African trypanosomiasis

  2000cited by this paper
• Treatment of human African trypanosomiasis.

  2000cited by this paper
• Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.

  2000cited by this paper
• The pathogenesis and modulation of the post-treatment reactive encephalopathy in a mouse model of Human African Trypanosomiasis.

  1999cited by this paper
• Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda.

  1999cited by this paper
• Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee.

  1998cited by this paper
• A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei.

  1997cited by this paper
• Human African trypanosomiasis: MRI

  1997cited by this paper
• Landmarks in trypanosome research.

  1997influential reference
• The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis

  1997cited by this paper
• The Wellcome Trust illustrated history of tropical diseases

  1997influential reference
• Trypanosoma brucei and the nervous system.

  1994cited by this paper
• From trypanosomes to the nervous system, from molecules to behavior: A survey, on the occasion of the 90th anniversary of Castellani's discovery of the parasites in sleeping sickness

  1994cited by this paper
• The treatment of human African trypanosomiasis.

  1994cited by this paper
• Current situation of African trypanosomiasis.

  1993cited by this paper
• The use of azathioprine to ameliorate post‐treatment encephalopathy associated with African trypanosomiasis

  1992cited by this paper
• Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei-infected mice.

  1992cited by this paper
• Subcurative chemotherapy and fatal post-treatment reactive encephalopathies in African trypanosomiasis.

  1992cited by this paper
• Immunopathology of experimental African sleeping sickness: detection of cytokine mRNA in the brains of Trypanosoma brucei brucei-infected mice

  1991cited by this paper
• Future prospects for the chemotherapy of human trypanosomiasis. 1. Novel approaches to the chemotherapy of trypanosomiasis.

  1990cited by this paper
• Spread of Trypanosoma brucei to the nervous system: Early attack on circumventricular organs and sensory ganglia

  1988cited by this paper
• Book Review: Epidemiology and Control of African Trypanosomiasis

  1987cited by this paper
• Epidemiology and control of African trypanosomiasis. Report of a WHO Expert Committee.

  1986cited by this paper
• HUMAN AFRICAN TRYPANOSOMIASIS (T.b. GAMBIENSE): A STUDY OF 16 FATAL CASES OF SLEEPING SICKNESS WITH SOME OBSERVATIONS ON ACUTE REACTIVE ARSENICAL ENCEPHALOPATHY

  1986cited by this paper
• Sleeping sickness in Europeans: a review of 109 cases.

  1966cited by this paper
• Sleeping sickness in Europeans: a review of 109 cases.

  1966cited by this paper

• Spiroplasma endosymbiont reduction of host lipid synthesis and Stomoxyn-like peptide contribute to trypanosome resistance in the tsetse fly Glossina fuscipes

  2025cites this paper
• Synthesis of pyrazolyl acrylamide-chalcone conjugates with sub-micromolar antitrypanosomal activities

  2025cites this paper
• Integrative analysis of single-cell and bulk transcriptomes reveals metabolic heterogeneity and identifies PFKP as a therapeutic target in cervical cancer.

  2025cites this paper
• Traitement oral de la trypanosomiase humaine africaine : faisabilité dans les communautés du littoral Guinéen

  2025cites this paper
• Human African Trypanosomiasis (HAT): Epidemiology, Biological Diagnosis and Treatment: A Review

  2025cites this paper
• Spiroplasma endosymbiont reduction of host lipid synthesis and Stomoxyn-like peptide contribute to trypanosome resistance in the tsetse fly Glossina fuscipes

  2024cites this paper
• Oximic compounds as potential inhibitors of metacaspase-2 (TbMCA2) of Trypanosoma brucei.

  2024cites this paper
• Suramin inhibits phenotypic transformation of vascular smooth muscle cells and neointima hyperplasia by suppressing transforming growth factor beta receptor 1 /Smad2/3 pathway activation.

  2024cites this paper
• Phytochemical Analysis, Cytotoxicity, and Antitrypanosomal, Antioxidant, and Anti-Inflammatory Activities of Clausena anisata Fruit, Azadirachta indica Leaf, and Stem Bark Extracts

  2024cites this paper
• Thiazolidin-4-one-based derivatives - Efficient tools for designing antiprotozoal agents. A review of the last decade.

  2023cites this paper
• Current developments on the antimalarial, antileishmanial, and antitrypanosomal potential and mechanisms of action of Terminalia spp

  2023cites this paper
• The Evolving Spectrum of Human African Trypanosomiasis.

  2023cites this paper
• Human African Trypanosomiasis (Sleeping Sickness)—Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention

  2023cites this paper
• Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies

  2023cites this paper
• Stressful Situations: Investigating Cell Death Pathways in Protozoal Parasite Crithidia fasciculata

  2022cites this paper
• Discovery of novel natural products as rhodesain inhibitors for human African trypanosomiasis using in silico techniques

  2022cites this paper
• Current Treatments to Control African Trypanosomiasis and One Health Perspective

  2022cites this paper
• Unusual neurological presentation of second stage African trypanosomiasis in a young boy: a case report

  2022cites this paper
• Synthesis and in vitro antitrypanosomal evaluation of novel 6-heteroarylidene-substituted quinolone derivatives.

  2021cites this paper
• Prevalence and outcomes of malaria as co-infection among patients with human African trypanosomiasis: a systematic review and meta-analysis

  2021cites this paper
• Pharmacokinetic study of an anti-trypanosome agent with different formulations and administration routes in mice by HPLC-MS/MS.

  2021cites this paper
• Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases

  2021cites this paper
• Trypanocidal effect of aqueous and ethanolic extracts of Strychnos spinosa on white mice infected with Trypanosoma brucei brucei

  2021cites this paper
• Microarray profiling predicts early neurological and immune phenotypic traits in advance of CNS disease during disease progression in Trypanosoma. b. brucei infected CD1 mouse brains

  2021cites this paper
• Chiral Chromatographic Isolation on Milligram Scale of the Human African Trypanosomiasis Treatment d- and l-Eflornithine

  2020cites this paper
• Structure-activity relationship exploration of 3'-deoxy-7-deazapurine nucleoside analogues as anti-Trypanosoma brucei agents.

  2020cites this paper
• Experimental production of anti-membrane bound variable surface glycoglycoprotein (anti-VSGm) antibodies for in vitro and in situ immunostaining of pathogenic African trypanosomes

  2020cites this paper
• International Scientific Council for Trypanosomiasis Research and Control (ISCTRC)

  2020cites this paper
• Molecular Targeting of VEGF with a Suramin Fragment–DOCA Conjugate by Mimicking the Action of Low Molecular Weight Heparins

  2020cites this paper
• Repurposed Molecules: A New Hope in Tackling Neglected Infectious Diseases

  2019cites this paper
• Combining tubercidin and cordycepin scaffolds results in highly active candidates to treat late-stage sleeping sickness

  2019cites this paper
• Validation of a cross-NTD toolkit for assessment of NTD-related morbidity and disability. A cross-cultural qualitative validation of study instruments in Colombia

  2019cites this paper
• Active Essential Oils and Their Components in Use against Neglected Diseases and Arboviruses

  2019cites this paper
• Update on human African trypanosomiasis (sleeping sickness)

  2019cites this paper
• Thiazolidinone/thiazole based hybrids - New class of antitrypanosomal agents.

  2019cites this paper
• Plant-derived compounds against protozoan neglected diseases: toward sustainable drug development

  2019cites this paper
• Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis

  2019cites this paper
• Promising trypanocidal heterocyclic compounds of natural origin and their synthetic analogs

  2019cites this paper
• Political Stability, Corruption, Democracy and Terrorism In the Middle East and North Africa

  2019cites this paper
• The composition and abundance of bacterial communities residing in the gut of Glossina palpalis palpalis captured in two sites of southern Cameroon

  2019cites this paper
• Comparative structural genomics and phylogenomics of African Trypanosomes

  2018cites this paper
• Neural Damage in Experimental Trypanosoma brucei gambiense Infection: The Suprachiasmatic Nucleus

  2018cites this paper
• A FRET flow cytometry method for monitoring cytosolic and glycosomal glucose in living kinetoplastid parasites

  2018cites this paper
• African Trypanosomiasis-Associated Anemia: The Contribution of the Interplay between Parasites and the Mononuclear Phagocyte System

  2018cites this paper
• Synthesis, in vitro cytotoxicity and trypanocidal evaluation of novel 1,3,6-substituted non-fluoroquinolones

  2018cites this paper
• Novel Methods for Monitoring Glucose Metabolism in Trypanosoma brucei Using Fluorescent Biosensors

  2018cites this paper
• 23 – Infections and Inflammatory Disorders

  2018cites this paper
• Silent Information Regulator 2 from Trypanosoma cruzi Is a Potential Target to Infection Control

  2018cites this paper
• Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors

  2017cites this paper
• Role of Serodiagnosis of Human African Trypanosomiasis (Sleeping Sickness)

  2017cites this paper
• Elimination of sleeping sickness in Uganda could be jeopardised by conflict in South Sudan.

  2017cites this paper
• Plasma ACTH concentration and pituitary gland histo-pathology in rats infected with Trypanosoma brucei brucei

  2017cites this paper
• Assessment of Acetylcholinesterase, Creatine Kinase and Lactate Dehydrogenase as Biomarkers of Trypanosoma brucei Infection in Dogs

  2017cites this paper
• The challenging problem of disease staging in human African trypanosomiasis (sleeping sickness): a new approach to a circular question.

  2017cites this paper
• Instructions for use Title The use of Loop-mediated Isothermal Amplification ( LAMP ) to detect the re-emerging Human AfricanTrypanosomiasis ( HAT ) in the Luangwa and Zambezi valleys

  2017cites this paper
• Cell Cycle Inhibition To Treat Sleeping Sickness

  2017cites this paper
• Trypanosoma brucei Inhibition by Essential Oils from Medicinal and Aromatic Plants Traditionally Used in Cameroon (Azadirachta indica, Aframomum melegueta, Aframomum daniellii, Clausena anisata, Dichrostachys cinerea and Echinops giganteus)

  2017cites this paper
• Using proteomics to understand how parasites adapt to the host environment

  2017cites this paper
• A Brief Review of Drug Discovery Research for Human African Trypanosomiasis.

  2017cites this paper
• Chapter 27 – Human African Trypanosomiasis (Sleeping Sickness)

  2017cites this paper
• 116 – Fungal, Rickettsial, and Parasitic Diseases of the Nervous System

  2017cites this paper
• Phenolic Constituents of Medicinal Plants with Activity against Trypanosoma brucei

  2016cites this paper
• Structural characterization of TbFam50, TbPSSA2, and TcCISSA, surface proteins expressed by the trypanosome inside the tsetse vector

  2016influential citation
• Recent Development in Identification of Potential Novel Therapeutic Targets Against Trypanosomatids.

  2016cites this paper
• Les voies du transport intraflagellaire

  2016cites this paper
• Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense

  2016cites this paper
• Correction: Murine Models for Trypanosoma brucei gambiense Disease Progression—From Silent to Chronic Infections and Early Brain Tropism

  2016cites this paper
• Insect science – a vulnerable discipline?

  2016cites this paper
• Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis.

  2016cites this paper
• Scoping Studies into the Structure‐Activity Relationship (SAR) of Phenylephrine‐Derived Analogues as Inhibitors of Trypanosoma brucei rhodesiense

  2016cites this paper
• Synthesis and evaluation of analogs of the phenylpyridazinone NPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors and in vitro trypanocidals.

  2016cites this paper
• ASSESSMENT OF DONKEYS (Equus asinus) EXPERIMENTALLY INFECTED WITH Trypanosoma brucei (Federe isolate) AND TREATED WITH HOMIDIUM CHLORIDE AND ISOMETAMIDIUM CHLORIDE

  2016cites this paper
• Neurologic manifestations of the neglected tropical diseases.

  2015cites this paper
• The Impact of Nurses on Neglected Tropical Disease Management.

  2015cites this paper
• RNA-seq de novo Assembly Reveals Differential Gene Expression in Glossina palpalis gambiensis Infected with Trypanosoma brucei gambiense vs. Non-Infected and Self-Cured Flies

  2015cites this paper
• Vertical transmission of Bartonella schoenbuchensis in Lipoptena cervi

  2015cites this paper
• Chronic Infectious Inflammatory Diseases of the Central Nervous System

  2015cites this paper
• Virulence and pathogenicity of three Trypanosoma brucei rhodesiense stabilates in a Swiss white mouse model

  2015cites this paper
• Downstream effectors of cyclic adenosine monophosphate signalling in Trypanosoma brucei

  2015cites this paper
• An agent-based model to simulate tsetse fly distribution and control techniques: a case study in Nguruman, Kenya.

  2015cites this paper
• The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!

  2015cites this paper
• Interleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness

  2015cites this paper
• Identification, écologie et utilisation des diptères hématophages (glossine, stomoxe et tabanide) comme moyen d'échantillonnage non-invasif de la faune sauvage dans quatre parcs du Gabon

  2015cites this paper
• Comparative gene expression of Wigglesworthia inhabiting non-infected and Trypanosoma brucei gambiense-infected Glossina palpalis gambiensis flies

  2014cites this paper
• An Arginine-Glycine-Rich RNA Binding Protein Impacts the Abundance of Specific mRNAs in the Mitochondria of Trypanosoma brucei

  2014cites this paper
• Enhancing Physicochemical Properties through Synthesis and Formulation of Piclamilast- and Lapatinib-Derived Analogs

  2014cites this paper
• Adult blood-feeding tsetse flies, trypanosomes, microbiota and the fluctuating environment in sub-Saharan Africa

  2014cites this paper
• New drugs with antiprotozoal activity from marine algae: a review

  2014cites this paper
• Unravelling Human Trypanotolerance: IL8 is Associated with Infection Control whereas IL10 and TNFα Are Associated with Subsequent Disease Development

  2014cites this paper
• Trypanosoma Brucei Telomere Functions In Antigenic Variation

  2014cites this paper
• Trends in research of antitrypanosomal agents among synthetic heterocycles.

  2014influential citation
• Neurobiology of African Trypanosomiasis

  2014cites this paper
• Anti-trypanosomal activity of diarylheptanoids isolated from the bark of Alnus japonica.

  2014cites this paper
• Neglected Tropical Diseases and Conditions of the Nervous System

  2014cites this paper
• The journey towards elimination of gambiense human African trypanosomiasis: not far, nor easy

  2014cites this paper
• Anti-trypanosomal Activity of Potential Inhibitors of Trypanosoma Brucei Glycolytic Pathway Enzymes Selected by Docking Studies

  2014cites this paper
• Enantiospecific Reassessment of the Pharmacokinetics and Pharmacodynamics of Oral Eflornithine against Late-Stage Trypanosoma brucei gambiense Sleeping Sickness

  2014influential citation
• In vitro studies and in vivo evaluation of novel diamidines for 2nd stage sleeping sickness

  2014cites this paper
• Drug repurposing and human parasitic protozoan diseases

  2014cites this paper
• Crystal structure of 4-chloro-2-nitrobenzoic acid, C7H4ClNO4

  2013cites this paper